SARS-CoV-2 fusion-inhibitory lipopeptides maintain high potency against divergent variants of concern including OmicronSARS-CoV-2 융합 억제 리포펩티드는 오미크론을 포함한 다양한 관심 변종에 대해 높은 효능을 유지합니다Article Published on 2022-12-012022-09-11 Journal: Emerging Microbes & Infections [Category] COVID19(2023년), SARS, 변종, 치료제, [키워드] activity Alpha antiviral activity Beta broad-spectrum antiviral broad-spectrum antivirals Cell Cell fusion cell-cell fusion combating COVID-19 pandemic D614G Delta drugs effective vaccine Effective vaccines exhibited FIVE fusion inhibitor Gamma Impact Infection inhibiting inhibitor inhibitors Lambda lipopeptide maintain mutant omicron Omicron variant other variant other variants outbreak pseudovirus pseudovirus pseudovirus infection pseudoviruses reduced S protein S proteins SARS-CoV-2 significantly the S protein therapeutic variant variants variants of concern variants of concern. VoC VOCs wild-type WT virus [DOI] 10.1080/22221751.2022.2098060 PMC 바로가기 [Article Type] Article
A review on computer-aided chemogenomics and drug repositioning for rational COVID-19 drug discoveryArticle Published on 2022-11-012022-11-15 Journal: Chemical biology & drug design [Category] 변종, 신약개발, 치료기술, 치료제, [키워드] analyzed application assist chemogenomics compounds Computational drug computational drug discovery Computational methods coronavirus coronavirus disease CoV COVID-19 CoVs drug candidate Drug discovery drug repositioning drugs Efficiency epidemic diseases example feasible Host in silico approaches molecular docking other variants outcome Polypharmacology polypharmacology. Protein provide reflected reported Spread therapeutic target time-consuming Toxicity turn unique virus virus [DOI] 10.1111/cbdd.14136 PMC 바로가기
Accurate identification of SARS-CoV-2 variant delta using graphene/CRISPR-dCas9 electrochemical biosensorArticle Published on 2022-11-012022-11-15 Journal: Talanta [Category] COVID19(2023년), SARS, 변종, 치료기술, [키워드] Accurate identification amplified B.1.617.2 Beta clinical samples clinical sensitivity clinical specificity CRISPR-dCas9 Delta Detection limit develop electrochemical biosensor Gamma identify other variants probe provide reproducibility SARS-CoV-2 SARS-CoV-2 variant selective the SARS-CoV-2 variant Variant delta. variant of SARS-CoV-2 [DOI] 10.1016/j.talanta.2022.123687 PMC 바로가기
Comparison of COVID-19 pneumonia during the SARS-CoV-2 Omicron wave and the previous non-Omicron wave in a single facilityArticle Published on 2022-11-012022-11-16 Journal: Respiratory investigation [Category] SARS, 변종, [키워드] acute respiratory syndrome addition caused characteristic Characteristics Chest CT Cluster-like ground-glass opacities Computed tomography consolidation coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 described disease distribution enrolled evaluated GGO GGOs ground-glass opacity groups hospital omicron Omicron variant other variants patients with COVID-19 Pneumonia pneumonia. predominant Prevalence random replicate significantly lower the SARS-CoV-2 variant variants [DOI] 10.1016/j.resinv.2022.08.001 PMC 바로가기
Temperature Influences the Interaction between SARS-CoV-2 Spike from Omicron Subvariants and Human ACE2Article Published on 2022-09-302022-11-16 Journal: Viruses [Category] SARS, 변종, [키워드] ACE2 ACE2 affinity ACE2 receptor Affect arising BA.4 BA.5 COVID-19 domain enzyme glycoprotein Human immunogenic include infect influence Interaction multiple mutation mutated omicron other variants plasma RBD receptor SARS-CoV-2 shown significantly increased spike spike glycoprotein temperature the Spike translate Transmission vaccinated individuals variant Variant of concern. Viral transmission VoC [DOI] 10.3390/v14102178 PMC 바로가기
Vaccination Decreases the Infectious Viral Load of Delta Variant SARS-CoV-2 in Asymptomatic PatientsArticle Published on 2022-09-182022-11-15 Journal: Viruses [Category] SARS, 변종, 진단, [키워드] affecting Anti-spike asymptomatic infection asymptomatic infections B.1.617.2 breakthrough Breakthrough infection caused collected COVID-19 decrease Delta delta variant IgA individual Infectious virus load nasal Nasopharyngeal swab nasopharyngeal swabs other variants patients quantified risk SARS-CoV-2 secretion significantly higher Symptomatic patients Transmission vaccinated individuals vaccination vaccination. Vaccine vaccinee Viral load Viral RNA viral RNA genome while [DOI] 10.3390/v14092071 PMC 바로가기
Antigenic cartography using sera from sequence-confirmed SARS-CoV-2 variants of concern infections reveals antigenic divergence of OmicronArticle Published on 2022-09-132022-11-15 Journal: Immunity [Category] SARS, 변종, 진단, [키워드] antibodies antigenic antigenic cartography circulating variants convalescent COVID-19 D614G death Effectiveness elicited Evolution had more Hospitalization Immune escape Immunity individual Infection neutralization Neutralizing activity omicron other variants Patient prevented question responses reveal SARS-CoV-2 SARS-CoV-2 vaccine SARS-CoV-2 variant Seasonal influenza sera strain vaccination Vaccine Vaccines variants of concern variants of concern. virus VoC VOCs [DOI] 10.1016/j.immuni.2022.07.018 PMC 바로가기
Plasma and memory antibody responses to Gamma SARS-CoV-2 provide limited cross-protection to other variants감마 SARS-CoV-2에 대한 혈장 및 기억 항체 반응은 다른 변이체에 대해 제한된 교차 보호를 제공합니다Article Published on 2022-09-052022-09-11 Journal: The Journal of Experimental Medicine [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus antibody Antibody Response Beta class Cohort coronavirus cross-protection Delta elicited Epitopes evade exposure to Gamma Hospitalized implication individuals infected individual infected individuals Infection infections memory memory B cell memory B cells memory response monoclonal antibodies neutralization neutralize neutralized Neutralizing activity Neutralizing antibodies neutralizing antibody omicron other variant other variants plasma provide pseudotyped pseudovirus pseudoviruses respiratory SARS-CoV-2 SARS-CoV-2 spike protein severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 significantly lower Spike protein vaccination variant variant-specific vaccine variant-specific vaccines variants variants of concern virus viruses Wuhan Wuhan-Hu-1 [DOI] 10.1084/jem.20220367 PMC 바로가기 [Article Type] Article
Clinical manifestations of COVID-19 breakthrough infections: A systematic review and meta-analysisCOVID-19 돌발 감염의 임상 양상: 체계적인 검토 및 메타 분석Meta-Analysis Published on 2022-09-012022-09-11 Journal: Journal of medical virology [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI 95% confidence interval Analysis asymptomatic infection Breakthrough infection breakthrough infections clinical manifestation clinical manifestations Clinical outcome Coronavirus 2019 COVID-19 COVID-19 infection COVID-19 infections Delta delta variant Effect Effectiveness examined groups heterogeneity Hospitalization individual individuals Infection Invasive mechanical ventilation Meta-analysis Mortality need for oxygen other variants oxygen oxygen supplementation Patient Relative risk risk Risk factors risk of infection significantly significantly higher statistically statistically significant difference Still study heterogeneity supplemental oxygen systematic review Treatment strategies Vaccine vaccine effectiveness. variant variants Web of Science [DOI] 10.1002/jmv.27871 PMC 바로가기 [Article Type] Meta-Analysis
Different efficacies of neutralizing antibodies and antiviral drugs on SARS-CoV-2 Omicron subvariants, BA.1 and BA.2SARS-CoV-2 Omicron subvariants, BA.1 및 BA.2에 대한 중화 항체 및 항바이러스 약물의 다양한 효능Article Published on 2022-09-012022-09-11 Journal: Antiviral Research [Category] COVID19(2023년), SARS, 변종, 진단, 치료제, [키워드] activity acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Alpha analysis Analysis antibodies antibody Antiviral antiviral drug antiviral drugs Antiviral effect antiviral effects BA.1 BA.2 Casirivimab Cell culture concentrations conserved coronavirus Delta drug treatment Efficacy EIDD-1931 Evidence FIVE Gamma Imdevimab Infection intrinsic mathematical molnupiravir Neutralizing antibodies neutralizing antibody Nirmatrelvir omicron other variant other variants quantified replacing respiratory SARS-CoV-2 sensitivity severe acute respiratory syndrome Coronavirus Sotrovimab Sotrovimab. Spread Treatment variant variants Viral [DOI] 10.1016/j.antiviral.2022.105372 PMC 바로가기 [Article Type] Article